Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

Robert Edward Kelly net worth and biography

Robert Kelly Biography and Net Worth

EVP of Zoetis

Mr. Robert Kelly is the EVP of Zoetis.

What is Robert Edward Kelly's net worth?: The estimated net worth of Robert Edward Kelly is at least $1.65 million as of February 11th, 2021. Mr. Kelly owns 10,029 shares of Zoetis stock worth more than $1,653,180 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Kelly may own. Learn More about Robert Edward Kelly's net worth.
How do I contact Robert Edward Kelly?: The corporate mailing address for Mr. Kelly and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Robert Edward Kelly's contact information.
Has Robert Edward Kelly been buying or selling shares of Zoetis?: Robert Edward Kelly has not been actively trading shares of Zoetis over the course of the past ninety days. Most recently, Robert Edward Kelly sold 2,055 shares of the business's stock in a transaction on Thursday, April 1st. The shares were sold at an average price of $158.05, for a transaction totalling $324,792.75. Learn More on Robert Edward Kelly's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO & Director), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 4 times. They sold a total of 3,132 shares worth more than $547,983.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Robert Edward Kelly Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
4/1/2021	Sell	2,055	$158.05	$324,792.75
2/11/2021	Sell	2,054	$161.15	$331,002.10	10,029

Robert Edward Kelly Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $164.84

$163.53

$166.39

50 Day Range

MA: $178.52

$163.52

$194.45

2 Week Range

Now: $164.84

$144.80

$200.53

Volume

6,184,068 shs

Average Volume

2,552,173 shs

Market Capitalization

$74.37 billion

P/E Ratio

30.99

Dividend Yield

1.03%

Beta

0.89

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.